Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (111-120 of 229) with videos related to

Pageof 23
Sort By:
World Journal of Surgery|February 13, 2004
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrenceTeh-Ia Huo, Wing-Yu Lui, Jaw-Ching Wu, et al.
Journal of the Chinese Medical Association : JCMA|May 22, 2018
The effects of proton pump inhibitor on hepatic vascular responsiveness and hemodynamics in cirrhotic ratsI-Fang Hsin, Shao-Jung Hsu, Chiao-Lin Chuang, et al.
Journal of Gastroenterology and Hepatology|April 14, 2012
Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationYun-Hsuan Lee, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Annals of Surgical Oncology|October 19, 2014
Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysisChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Medicine|October 16, 2015
Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral EtiologyPo-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, et al.
Medicine|December 20, 2014
Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysisPo-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, et al.
Journal of Surgical Oncology|February 4, 2015
Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinomaPo-Hong Liu, Cheng-Yuan Hsia, Yun-Hsuan Lee, et al.
Digestive Diseases and Sciences|June 18, 2020
Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationShu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
Pageof 23

Showing results (111-120 of 229) with videos related to

Sort By:
Pageof 23
World Journal of Surgery|February 13, 2004
Deterioration of hepatic functional reserve in patients with hepatocellular carcinoma after resection: incidence, risk factors, and association with intrahepatic tumor recurrenceTeh-Ia Huo, Wing-Yu Lui, Jaw-Ching Wu, et al.
Journal of the Chinese Medical Association : JCMA|May 22, 2018
The effects of proton pump inhibitor on hepatic vascular responsiveness and hemodynamics in cirrhotic ratsI-Fang Hsin, Shao-Jung Hsu, Chiao-Lin Chuang, et al.
Journal of Gastroenterology and Hepatology|April 14, 2012
Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolizationYun-Hsuan Lee, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Annals of Surgical Oncology|October 19, 2014
Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysisChia-Yang Hsu, Po-Hong Liu, Yun-Hsuan Lee, et al.
Medicine|October 16, 2015
Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral EtiologyPo-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, et al.
Medicine|December 20, 2014
Uncompromised treatment efficacy in elderly patients with hepatocellular carcinoma: a propensity score analysisPo-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, et al.
Journal of Surgical Oncology|February 4, 2015
Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinomaPo-Hong Liu, Cheng-Yuan Hsia, Yun-Hsuan Lee, et al.
Digestive Diseases and Sciences|June 18, 2020
Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationShu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, et al.
Journal of Gastrointestinal Cancer|May 31, 2022
Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysisGauri Mishra, Ammar Majeed, Anouk Dev, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2020
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinomaPo-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, et al.
Pageof 23